This inventor holds 1 USPTO granted patent. Top assignee: Ariceum Therapeutics Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Didier Kubiak: Innovator in Radiopharmaceuticals
Introduction
Didier Kubiak is a notable inventor based in Dreux, France. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative work on somatostatin analogues. His expertise and dedication to advancing medical technology have positioned him as a key figure in his industry.
Latest Patents
Kubiak holds a patent for a composition containing a somatostatin analogue for radiopharmaceutical use. This invention is particularly relevant for diagnostic or therapeutic applications. The somatostatin analogue he developed is a receptor-selective somatostatin peptide antagonist, showcasing his commitment to enhancing medical treatments.
Career Highlights
Kubiak is currently associated with Ariceum Therapeutics GmbH, where he continues to push the boundaries of innovation in the pharmaceutical sector. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients.
Collaborations
Some of his notable coworkers include Romain Bejot and Bilal Karaaoui. Their collaborative efforts have further enriched the research environment at Ariceum Therapeutics GmbH.
Conclusion
Didier Kubiak's contributions to the field of radiopharmaceuticals exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that may lead to improved health outcomes for many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile